Eagle is attending the 2023 PDA Pharmaceutical Microbiology Conference taking place this October 2nd – 4th in Washington DC.
This conference addresses the most relevant opportunities and challenges to the future of microbiology in our global market. Meet professionals from all facets of the global industry, academia, and regulatory authorities, who will share insights on how to best prepare for the future through best practices, development of standards, and integration of innovative technologies.
We look forward to seeing you there.
Eagle is a U.S. Food and Drug Administration (FDA) and Drug Enforcement Agency (DEA) registered A2LA ISO 17025 accredited laboratory founded in 2003 that provides analytical chemistry and microbiological testing, consultation services, and other technical services for pharmacies, highly regulated industries, and research organizations to support their compliance needs.
Latest posts by Eagle Analytical (see all)
- Antimicrobial Effectiveness | USP 795 & 797 Revisions - July 18, 2023
- 2023 PDA/FDA Joint Regulatory Conference, 09/18 – 09/20 - July 11, 2023
- APC: Compounders on Capitol Hill, 09/19 – 09/20 - July 11, 2023
